← Leaderboards
Adam L Boxer
Mayo Clinic Rochester
$75,127,044
Attributed
$134,032,133
Total exposure
19
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $61.3M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$222,914,514 · 21
By mechanism
R01$112,912,431 · 5
U19$89,034,208 · 5
U54$12,621,100 · 8
R56$6,065,228 · 1
P01$1,518,895 · 1
K23$762,652 · 1
Top collaborators
- Bradley F Boeve13 shared
- Howard J Rosen13 shared
- Peter Alexander Ljubenkov4 shared
- Keith A. Johnson2 shared
- Irene Litvan2 shared
- Julio Cesar Rojas-Martinez2 shared
- Anne-Marie Wills2 shared
- Desiree A Byrd1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Keith A Josephs$19,660,217
- Rosa Rademakers$18,756,090
- Farwa Ali$920,756
- Rene Lynn Utianski$1,193,160
- William W Seeley$26,843,727
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposClinical TrialsFrontotemporal Lobar DegenerationsS DiseaseParticipantEnrollmentBiological MarkersResearch PersonnelTau ProteinsSyndromeMagnetic Resonance ImagingMutationNeurodegenerative DisordersBiologicalDesignEffective TherapyImagePathologyGenesMeasurementFamilyDiagnosisFutureEvaluation
Grant awards (90)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$16,947,844
U19 · FY2025 · AG
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)$14,499,067
R01 · FY2025 · AG · contact PI
Biofluid Core$1,580,507
U19 · FY2025 · AG · contact PI
Biospecimens$405,069
P01 · FY2025 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$331,127
U19 · FY2025 · AG
Project 2$274,101
U19 · FY2025 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$174,552
U19 · FY2025 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$123,012
U19 · FY2025 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)$89,338
U19 · FY2025 · AG
The Alzheimer's Disease Tau Platform Clinical Trial$29,813,375
R01 · FY2024 · AG · contact PI
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)$15,782,145
R01 · FY2024 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$13,195,325
U19 · FY2024 · AG
Biofluid Core$984,055
U19 · FY2024 · AG · contact PI
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP$633,691
R01 · FY2024 · AG
Biospecimens$556,921
P01 · FY2024 · AG · contact PI
Project 2$376,375
U19 · FY2024 · AG · contact PI
The Alzheimer's Disease Tau Platform Clinical Trial$30,887,229
R01 · FY2023 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,618,678
U19 · FY2023 · AG
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP$638,870
R01 · FY2023 · AG
Biospecimens$556,905
P01 · FY2023 · AG · contact PI
Project 2$376,375
U19 · FY2023 · AG · contact PI
Biofluid Core$293,894
U19 · FY2023 · AG · contact PI
Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)$6,065,228
R56 · FY2022 · AG · contact PI
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP$640,216
R01 · FY2022 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$13,002,977
U19 · FY2021 · AG
Biofluid Core$868,029
U19 · FY2021 · AG · contact PI
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP$677,137
R01 · FY2021 · AG
Project 2$376,374
U19 · FY2021 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$221,979
U19 · FY2021 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,228,673
U19 · FY2020 · AG
The Four Repeat Tauopathy Neuroimaging Initiative$2,549,244
R01 · FY2020 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - (Remote Monitoring FTLD Supplement)$419,685
U19 · FY2020 · AG
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$393,850
U19 · FY2020 · AG
Project 2$376,374
U19 · FY2020 · AG · contact PI
Biofluid Core$293,894
U19 · FY2020 · AG · contact PI
Biofluid Core$28,333
U19 · FY2020 · AG · contact PI
Project 2$11,643
U19 · FY2020 · AG · contact PI
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)$12,764,241
U19 · FY2019 · AG
The Four Repeat Tauopathy Neuroimaging Initiative$3,154,975
R01 · FY2019 · AG · contact PI
Project 2$389,456
U19 · FY2019 · AG · contact PI
Biofluid Core$293,517
U19 · FY2019 · AG · contact PI
The Four Repeat Tauopathy Neuroimaging Initiative$3,156,502
R01 · FY2018 · AG · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$1,250,000
U54 · FY2018 · NS · contact PI
Project 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$638,169
U54 · FY2018 · NS · contact PI
Project 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$239,512
U54 · FY2018 · NS · contact PI
Admin Core - The Frontotemporal Lobar Degeneration Clinical Research Consortium$223,144
U54 · FY2018 · NS · contact PI
Training - The Frontotemporal Lobar Degeneration Clinical Research Consortium$87,165
U54 · FY2018 · NS · contact PI
Pilot 3 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$62,010
U54 · FY2018 · NS · contact PI
The Four Repeat Tauopathy Neuroimaging Initiative$3,164,662
R01 · FY2017 · AG · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$1,250,000
U54 · FY2017 · NS · contact PI
Project 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$638,168
U54 · FY2017 · NS · contact PI
Project 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$238,909
U54 · FY2017 · NS · contact PI
Admin Core - The Frontotemporal Lobar Degeneration Clinical Research Consortium$223,433
U54 · FY2017 · NS · contact PI
Training - The Frontotemporal Lobar Degeneration Clinical Research Consortium$87,165
U54 · FY2017 · NS · contact PI
Pilot 3 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$62,325
U54 · FY2017 · NS · contact PI
The Four Repeat Tauopathy Neuroimaging Initiative$3,247,823
R01 · FY2016 · AG · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$1,250,000
U54 · FY2016 · NS · contact PI
Project 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$636,757
U54 · FY2016 · NS · contact PI
Project 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$236,392
U54 · FY2016 · NS · contact PI
Admin Core - The Frontotemporal Lobar Degeneration Clinical Research Consortium$222,010
U54 · FY2016 · NS · contact PI
Training - The Frontotemporal Lobar Degeneration Clinical Research Consortium$85,893
U54 · FY2016 · NS · contact PI
Pilot 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$68,948
U54 · FY2016 · NS · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$1,250,000
U54 · FY2015 · NS · contact PI
Project 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$635,328
U54 · FY2015 · NS · contact PI
Project 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$229,446
U54 · FY2015 · NS · contact PI
Admin Core - The Frontotemporal Lobar Degeneration Clinical Research Consortium$225,674
U54 · FY2015 · NS · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$121,100
U54 · FY2015 · NS · contact PI
Training - The Frontotemporal Lobar Degeneration Clinical Research Consortium$84,599
U54 · FY2015 · NS · contact PI
Pilot 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$74,953
U54 · FY2015 · NS · contact PI
The Frontotemporal Lobar Degeneration Clinical Research Consortium$1,250,000
U54 · FY2014 · NS · contact PI
Project 2 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$693,943
U54 · FY2014 · NS · contact PI
Four Repeat Tauopathy Neuroimaging Initiative$548,857
R01 · FY2014 · AG · contact PI
Admin Core - The Frontotemporal Lobar Degeneration Clinical Research Consortium$243,234
U54 · FY2014 · NS · contact PI
Project 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$155,863
U54 · FY2014 · NS · contact PI
Training - The Frontotemporal Lobar Degeneration Clinical Research Consortium$83,073
U54 · FY2014 · NS · contact PI
Pilot 1 - The Frontotemporal Lobar Degeneration Clinical Research Consortium$73,887
U54 · FY2014 · NS · contact PI
Four Repeat Tauopathy Neuroimaging Initiative$523,752
R01 · FY2013 · AG · contact PI
Eye Movement Control in Normal Elderly and MCI$257,195
R01 · FY2013 · AG · contact PI
Four Repeat Tauopathy Neuroimaging Initiative$546,286
R01 · FY2012 · AG · contact PI
Eye Movement Control in Normal Elderly and MCI$272,726
R01 · FY2012 · AG · contact PI
Four Repeat Tauopathy Neuroimaging Initiative$581,440
R01 · FY2011 · AG · contact PI
Eye Movement Control in Normal Elderly and MCI$230,932
R01 · FY2011 · AG · contact PI
Four Repeat Tauopathy Neuroimaging Initiative$623,182
R01 · FY2010 · AG · contact PI
Eye Movement Control in Normal Elderly and MCI$240,675
R01 · FY2010 · AG · contact PI
Eye Movement Control in Normal Elderly and MCI$242,450
R01 · FY2009 · AG · contact PI
Ocular motor function and decision-making in FTLD$160,963
K23 · FY2009 · NS · contact PI
Ocular motor function and decision-making in FTLD$160,963
K23 · FY2008 · NS · contact PI
Ocular motor function and decision-making in FTLD$160,963
K23 · FY2007 · NS · contact PI
Ocular motor function and decision-making in FTLD$160,963
K23 · FY2006 · NS · contact PI
Ocular motor function and decision-making in FTLD$118,800
K23 · FY2005 · NS